Article Details

BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165

Retrieved on: 2022-12-23 08:22:14

Tags for this article:

Click the tags to see associated articles and topics

BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165. View article details on hiswai:

Excerpt

BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention based on a novel multi-antigen vaccine approachFirst evaluated ...

Article found on: www.ottumwacourier.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up